Top Markets
#1 Black Phoenix Black Phoenix +166.47%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Test Test +21.69%
#5 Cryptopia Cryptopia +21.05%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#7 MarsCoin MarsCoin +12.42%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.89%
#9 Palladium Network Palladium Network +9.29%
#10 Useless Coin Useless Coin +8.92%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien

MER
Classifica tra le azioni #342
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Prezzo delle azioni
$171.67
Ultima sincronizzazione: 2026-07-13
Capitalizzazione di mercato
$74.64B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-
Paese
DE
Scambia MERCK Kommanditgesellschaft auf Aktien (MER)

Categoria

Healthcare
Utile per MERCK Kommanditgesellschaft auf Aktien (MER)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MERCK Kommanditgesellschaft auf Aktien, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di MERCK Kommanditgesellschaft auf Aktien dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
600276.SS
- -
CN